ProMIS Neurosciences, Inc.
NASDAQ:PMNBiotechnology
-$0.02 today
- Market cap
- $99.36M
- Beta
- -0.22
- P/E (TTM)
- -0.6
- EPS (TTM)
- -$4.62
Volume 0.13M
Average 0.07M
PMN Total Current Liabilities
All obligations due within one year.
ProMIS Neurosciences, Inc.NASDAQ: PMN
Total Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total current liabilities falls 26.5% from a year ago
Total current liabilities stood at $7.22M at the end of Q2 FY2026, down 26.5% from a year earlier and up 9.1% from the prior quarter. Over 3 fiscal years it compounded at -3.7% a year.
Context
- Total current liabilities amounted to 12.7% of total assets at the end of Q2 FY2026, down 90.6 pp from a year earlier.
- Total current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total current liabilities keeps falling in the next quarterly balance sheet after a -26.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
Mixed currencies · from the balance sheet
- Latest · FY2025
- 10.41M USD
- Year-over-year change
- +369.3%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.41M | +369.3% |
| FY2024 | 2024-12-31 | 2.22M | -76.3% |
| FY2023 | 2023-12-31 | 9.35M | — |
| FY2022 | 2022-12-31 | 11.67M | +893.1% |
| FY2021 | 2021-12-31 | 1.17M | — |
Total Current Liabilities vs competitors
How PMN compares with its peers on the latest reported figures
- PMN's Jun 2026 total current liabilities of $7.22M is the 3rd highest of the 4 companies compared; the peer median is $14.28M.
- Its year-over-year change of -26.5% is the lowest of 4, against a peer median of +10.0%.
- Total current liabilities amounts to 12.7% of total assets for PMN, versus a peer median of 17.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $41.63M | -8.2% | -48.9% | 120.9% | |
| Mar 2026 | $14.28M | +10.0% | +8.8% | 3.4% | |
| Jun 2026 | $7.22M | -26.5% | -3.7% | 12.7% | |
| Mar 2026 | $2.19M | +139.2% | -20.4% | 17.7% | |
| Peer median (excluding PMN) | $14.28M | +10.0% | -20.4% | 17.7% | |
Competitors are the stored peer set for PMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 · CAD | FY2022 Dec 2022 · CAD | FY2023 Dec 2023 · USD | FY2024 Dec 2024 · USD | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Cash & Equivalents | 21.43M | 10.69M | 12.6M | 13.29M | 6.12M |
| Short-term Investments | 50.69K | 79.89K | 32.36K | 33.05K | 33.75K |
| Net Receivables | 0 | 0 | 78.64K | 78.03K | 36.52K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 768.78K | 768.19K | 228.85K | 47.28K | 70.48K |
| Total Current Assets | 22.4M | 12.56M | 13.62M | 18.91M | 9.18M |
| Property, Plant & Equipment (Net) | 5.91K | 584 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 34.92K | 37.91K | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Assets | 40.83K | 38.49K | 0 | 0 | 0 |
| Total Assets | 22.44M | 12.6M | 13.62M | 18.91M | 9.18M |
| Account Payables | 517.17K | 5.41M | 7.84M | 1.74M | 2.54M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 518.7K | 38.33K | 79.75K |
| Total Current Liabilities | 1.17M | 11.67M | 9.35M | 2.22M | 10.41M |
| Long-term Debt | 4.94M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 9.17M | 3.38M | 516.19K | 204.86K | 29.18K |
| Total Non-current Liabilities | 14.11M | 3.38M | 516.19K | 204.86K | 29.18K |
| Total Liabilities | 15.28M | 15.05M | 9.87M | 2.42M | 10.44M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (78.64M) | (146M) | (93.47M) | (90.69M) | (130.41M) |
| Accumulated OCI | (237.63K) | (355.42K) | (371.18K) | (371.18K) | (371.18K) |
| Other Stockholders Equity | 0 | 946 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 7.16M | (2.45M) | 3.75M | 16.49M | (1.26M) |
| Total Debt | 4.94M | 0 | 0 | 0 | 0 |
| Net Debt | (16.49M) | (10.69M) | (12.6M) | (13.29M) | (6.12M) |
ProMIS Neurosciences, Inc.
NASDAQ:PMN
Intrinsic Alpha fair value
Locked
Current Price
$11.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.